These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11958829)

  • 1. 5-HT(1A) receptor antagonist p-MPPI attenuates acute ethanol effects in mice and rats.
    Popova NK; Ivanova EA
    Neurosci Lett; 2002 Mar; 322(1):1-4. PubMed ID: 11958829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The selective 5-HT(1A) receptor antagonist p-MPPI antagonizes sleep--waking and behavioural effects of 8-OH-DPAT in rats.
    Sørensen E; Grønli J; Bjorvatn B; Ursin R
    Behav Brain Res; 2001 Jun; 121(1-2):181-7. PubMed ID: 11275295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sleep-wake effects following the selective 5-HT(1A) receptor antagonist p-MPPI in the freely moving rat.
    Sørensen E; Bjorvatn B; Ursin R
    Behav Brain Res; 2000 Sep; 114(1-2):31-8. PubMed ID: 10996044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4-(2'-Methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p-iodobenzamido]ethyl] piperazine and 4-(2'-methoxyphenyl)-1-[2'-[N-(2"-pyridinyl)-p- fluorobenzamido]ethyl]piperazine, two new antagonists at pre- and postsynaptic serotonin-1A receptors.
    Thielen RJ; Fangon NB; Frazer A
    J Pharmacol Exp Ther; 1996 May; 277(2):661-70. PubMed ID: 8627543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
    Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
    J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central 5-HT3 receptor-induced hypothermia in mice: interstrain differences and comparison with hypothermia mediated via 5-HT1A receptor.
    Naumenko VS; Kondaurova EM; Popova NK
    Neurosci Lett; 2009 Nov; 465(1):50-4. PubMed ID: 19735696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonergic manipulations both potentiate and reduce brain stimulation reward in rats: involvement of serotonin-1A receptors.
    Harrison AA; Markou A
    J Pharmacol Exp Ther; 2001 Apr; 297(1):316-25. PubMed ID: 11259559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of compounds varying in selectivity as 5-HT(1A) receptor antagonists in three rat models of anxiety.
    Griebel G; Rodgers RJ; Perrault G; Sanger DJ
    Neuropharmacology; 2000 Jul; 39(10):1848-57. PubMed ID: 10884565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine combined with a serotonin-1A receptor antagonist reversed reward deficits observed during nicotine and amphetamine withdrawal in rats.
    Harrison AA; Liem YT; Markou A
    Neuropsychopharmacology; 2001 Jul; 25(1):55-71. PubMed ID: 11377919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The 5-HT1A receptor antagonist p-MPPI blocks 5-HT1A autoreceptors and increases dorsal raphe unit activity in awake cats.
    Bjorvatn B; Fornal CA; Martín FJ; Metzler CW; Jacobs BL
    Eur J Pharmacol; 1998 Sep; 356(2-3):167-78. PubMed ID: 9774246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 8-OHDPAT-induced disruption of prepulse inhibition in rats is attenuated by prolonged corticosterone treatment.
    Czyrak A; Maćkowiak M; Chocyk A; Fijał K; Gadek-Michalska A; Wedzony K
    Neuropsychopharmacology; 2003 Jul; 28(7):1300-10. PubMed ID: 12700680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-OH-DPAT acts on both 5-HT1A and 5-HT7 receptors to induce hypothermia in rodents.
    Hedlund PB; Kelly L; Mazur C; Lovenberg T; Sutcliffe JG; Bonaventure P
    Eur J Pharmacol; 2004 Mar; 487(1-3):125-32. PubMed ID: 15033384
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sleep and waking following microdialysis perfusion of the selective 5-HT1A receptor antagonist p-MPPI into the dorsal raphe nucleus in the freely moving rat.
    Sørensen E; Grønli J; Bjorvatn B; Bjørkum A; Ursin R
    Brain Res; 2001 Apr; 897(1-2):122-30. PubMed ID: 11282365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in rat cerebral blood volume due to modulation of the 5-HT(1A) receptor measured with susceptibility enhanced contrast MRI.
    Scanley BE; Kennan RP; Gore JC
    Brain Res; 2001 Sep; 913(2):149-55. PubMed ID: 11549378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of several 5-hydroxytryptamine(1A) receptor ligands on the micturition reflex in rats: comparison with WAY 100635.
    Testa R; Guarneri L; Poggesi E; Angelico P; Velasco C; Ibba M; Cilia A; Motta G; Riva C; Leonardi A
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1258-69. PubMed ID: 10454502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiating effect of spinosin, a C-glycoside flavonoid of Semen Ziziphi spinosae, on pentobarbital-induced sleep may be related to postsynaptic 5-HT(1A) receptors.
    Wang LE; Cui XY; Cui SY; Cao JX; Zhang J; Zhang YH; Zhang QY; Bai YJ; Zhao YY
    Phytomedicine; 2010 May; 17(6):404-9. PubMed ID: 20171860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of WAY 100635 on antipsychotic-induced catalepsy in 5-HT depleted animals: a role for tonic activation of 5-HT(1A) receptors.
    Prinssen EP; Koek W; Kleven MS
    Eur J Pharmacol; 2000 Apr; 395(2):143-7. PubMed ID: 10794820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of 5-HT(1A) autoreceptors by a low chronic fluoxetine dose effect of the concurrent administration of WAY-100635.
    Hervás I; Vilaró MT; Romero L; Scorza MC; Mengod G; Artigas F
    Neuropsychopharmacology; 2001 Jan; 24(1):11-20. PubMed ID: 11106871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of novel 5-HT1A receptor antagonists on measures of post-synaptic 5-HT1A receptor activation in vivo.
    Thielen RJ; Frazer A
    Life Sci; 1995; 56(7):PL163-8. PubMed ID: 7869825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WAY-100635 antagonist-induced plasticity of 5-HT receptors: regulatory differences between a stable cell line and an in vivo native system.
    Khawaja XZ; Smith DL; Nawoschik SP; Zhang J; Dunlop J; Dilks DW; Olsen M; Schechter LE
    J Neurochem; 2006 Jul; 98(1):134-45. PubMed ID: 16805803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.